TPP decreases melanoma tumor growth rate when administered via hydrogel. حسب Kyle C. Kloepping (9928265)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. حسب Blake A. Shannon (14197601)

TG6-44 treatment decreases A/X31-induced ROS in THP-1 cells. حسب Juan A. De La Cruz (11154187)

Detection of epistasis is confined in a time window whose width is controlled by the mean selection coefficient. حسب Gabriele Pedruzzi (5753792)

eIF5a affects the expression of mitochondrial dynamics–related genes. حسب Dong Ma (584680)

الموضوعات:

SMC-specific knockout of Klf5 (smcKlf5^−/−) exacerbates the progression of Ang II–induced AAA by facilitating ROS formation. حسب Dong Ma (584680)

الموضوعات:

Klf5 down-regulation leads to human VSMC senescence. حسب Dong Ma (584680)

الموضوعات:

The correlation of the mitochondrial dynamics–related genes with Klf5 in mouse VSMCs. حسب Dong Ma (584680)

الموضوعات:

eIF5a interacts with Mfn1 and preserves mitochondrial integrity. حسب Dong Ma (584680)

الموضوعات:

Changes in the color parameters of cherry shrimp (<i>N</i>. <i>davidi</i> var. red) in different feed treatment groups^a over a 56-day period (mean ± SD, <i>n</i> = 20). حسب Wei-Wei Hou (3405947)

Klf5 expression is down-regulated in the ruptured human and experimental AAA. حسب Dong Ma (584680)

الموضوعات:

Klf5 deficiency in mouse VSMCs leads to mitochondrial fission. حسب Dong Ma (584680)

الموضوعات:

Effect of eIF5a and Mfn1 expression on mitochondrial morphology. حسب Dong Ma (584680)

الموضوعات:

The expression of eIF5a, Fis1, Pink1, Drp1, Mfn1, and Mtfr1 and the analysis of mitochondrial morphology. حسب Dong Ma (584680)

الموضوعات:

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. حسب Peeraya Ekchariyawat (3911113)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. حسب Jordan A. Gunning (18143970)

Nsp8 decreases antiviral immune and inflammatory responses and promotes SARS-CoV-2 infection. حسب Xiaolin Zhang (246784)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity حسب Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity حسب Mert Golcuk (10789806)

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. حسب Mark P. Labrecque (10011469)